Submit Manuscript  

Article Details


The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy

[ Vol. 17 , Issue. 4 ]

Author(s):

Yong Zhang, Zhen Tian, Jiajia Yuan, Chang Liu, Hong li Liu, Si Qi Ma and Bin Li*   Pages 320 - 326 ( 7 )

Abstract:


Introduction: Leber's Optic Hereditary Neuropathy (LHON) is a common cause of teenaged blindness in both eyes for which there is currently no effective treatment. In 1871, the German ophthalmologist Theodor Leber was the first to describe the clinical characteristics of his namesake disease, and through unremitting efforts over the past 100 years, researchers have continued to increase their understanding of LHON. In recent years, using gene therapy, several groups have obtained breakthroughs in the treatment of the disease.

Conclusion: In this article, we will review the challenging journey that researchers faced towards our current understanding of LHON, and describe the transition of gene therapy research for LHON from the bench to bedside.

Keywords:

Leber's optic hereditary neuropathy, Gene therapy, Translational medicine, Mitochondrial disease, MT-ND4, Allotopic expression technology.

Affiliation:

Department of Ophthalmology Shiyan, Hubei University of Medicine - Taihe Hospital, Hubei, Department of Ophthalmology Shiyan, Hubei University of Medicine - Taihe Hospital, Hubei, Department of Ophthalmology, Tongji Medical College, Huazhong University of Science and Technology - Tongji Hospital, Wuhan Shi, Department of Ophthalmology, Tongji Medical College, Huazhong University of Science and Technology - Tongji Hospital, Wuhan Shi, Department of Ophthalmology, Tongji Medical College, Huazhong University of Science and Technology - Tongji Hospital, Wuhan Shi, Department of Ophthalmology, Tongji Medical College, Huazhong University of Science and Technology - Tongji Hospital, Wuhan Shi, Department of Ophthalmology Shiyan, Hubei University of Medicine - Taihe Hospital, Hubei



Read Full-Text article